Management of multidrug-resistant organisms in health care settings, 2006.
about
Strategies to minimize antibiotic resistanceInfection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for InstitutesEffectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literatureThe mechanism and control of DNA transfer by the conjugative relaxase of resistance plasmid pCU1Evaluation of conceptual frameworks applicable to the study of isolation precautions effectivenessAssociation between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveRespiratory source control using a surgical mask: An in vitro studyEffectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infectionsThe Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative BacilliApplication of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care UnitThe Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care SettingThe Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature.Self-reported use of personal protective equipment among Chinese critical care clinicians during 2009 H1N1 influenza pandemic.Hospital epidemiology and infection control in acute-care settings.Antimicrobial stewardship in residential aged care facilities: need and readiness assessment.The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteriaUse of longitudinal surveillance data to assess the effectiveness of infection control in critical care.High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trialContact precautions for multidrug-resistant organisms: Current recommendations and actual practice.Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces.Tigecycline use in serious nosocomial infections: a drug use evaluation.Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial OriginBiofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype.Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009)Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilitiesMinimal intervention for controlling nosocomial transmission of methicillin-resistant staphylococcus aureus in resource limited setting with high endemicity.Evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry assisted, selective broth method to screen for vancomycin-resistant enterococci in patients at high riskThird-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards.Response to emerging infection leading to outbreak of linezolid-resistant enterococci.Active surveillance for asymptomatic colonization with multidrug-resistant gram negative bacilli among injured service members--a three year evaluationMethicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community.Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.
P2860
Q24607946-B913172B-1BDA-47A9-9023-C452A943ECD6Q26799202-0E3B72C9-86CE-4863-83DE-88CC977D385FQ27006759-316CBB83-B48C-4177-AF65-D73DD7A607B8Q27661390-00AACBD6-3018-4191-8355-8EFB423D759EQ28082962-D3ED73BE-3755-484E-A7FB-E46A27CAA2ACQ28268161-AB1B4978-A82C-4045-B2D8-C0F9BB9C8784Q28388806-AE9EB6A0-BCBD-4830-AB58-391CA3CE32A2Q28394731-4270BEA8-7196-4A1E-B93E-297A40D74BE6Q28477999-C0D9636A-F902-4ED0-BF37-E947CFA7CD91Q28546927-2883D91A-26C3-4A23-9C53-FC8B3D6AB1BCQ28555082-8B07B168-5F28-4CB0-AF5E-F363CBB785C4Q30234957-BDBA62A1-84A7-412E-A0B7-C1CAA93050C8Q30238945-336DB92F-C5DE-470D-BF6B-E3EAAC8526B5Q30251425-50D66E81-04E4-4ADD-8DAD-AC41087D48BCQ30274763-6DF2FDD8-661B-4E30-8C11-3F12275C0C1AQ30421042-72F11017-F870-4AD0-8EC4-1EF174B04AD8Q30429049-7AC1DA76-29E3-4232-87B7-541AA292507BQ30585570-43390717-BED4-4492-A6BA-69FCE45E2CF3Q33396218-E35DDB34-44AB-4564-A218-F4000B969DF9Q33508663-D162E172-0656-454A-8DE2-42F99FC55E39Q33630568-5B39CA23-2C02-4F72-A57E-94504D5A4F3EQ33632050-3B1BF6D7-B3AD-44C7-9FCA-653AEEDCA534Q33684299-2295AF2D-A610-4D7D-84C5-8791110F381BQ33686050-DB985E07-15C9-4175-8644-781E008457FAQ33709972-5AD55098-26A0-45AC-AF6B-700196889B79Q33727812-5054ADB7-8443-45B4-8836-71EE955146EFQ33736461-FB732FE6-F911-4102-8A56-D9E7925DDB94Q33755384-734F39E1-1084-449A-9EBC-1B4DBD95DF8FQ33773159-7E7989F0-B1B2-42DC-96C6-7193F4D43C37Q33779239-A28EEA37-19D7-4D3A-98FB-2A8BC2F36F9FQ33779725-4B46A241-EE0C-4AC2-80AE-4B0AF15B2A05Q33793175-B986B477-C689-4C2C-84B8-712F6D347996Q33810108-898C7B99-8033-4D59-BABE-FEACF3695247Q33842121-914761C3-9244-481A-BD9E-B0EE3D1A3D37Q33884094-496F095C-0F2D-4387-BF6A-B7BA375AE591Q33893775-AAB22651-9461-4DFA-9DF9-1BA80F281E30Q33970752-8F581FEE-B61E-4048-8D4E-2AEFCBF86758Q34009487-B0522D02-5199-4933-A819-ABCB512007D7Q34027016-09894404-1DA1-40F1-86DB-01417C0B044BQ34045350-0F8D7CB7-7803-4A02-A7AA-84EF913947EA
P2860
Management of multidrug-resistant organisms in health care settings, 2006.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of multidrug-resistant organisms in health care settings, 2006.
@en
Management of multidrug-resistant organisms in health care settings, 2006.
@nl
type
label
Management of multidrug-resistant organisms in health care settings, 2006.
@en
Management of multidrug-resistant organisms in health care settings, 2006.
@nl
prefLabel
Management of multidrug-resistant organisms in health care settings, 2006.
@en
Management of multidrug-resistant organisms in health care settings, 2006.
@nl
P2093
P1476
Management of multidrug-resistant organisms in health care settings, 2006.
@en
P2093
Emily Rhinehart
Healthcare Infection Control Practices Advisory Committee
Jane D Siegel
Linda Chiarello
Marguerite Jackson
P304
P356
10.1016/J.AJIC.2007.10.006
P433
10 Suppl 2
P577
2007-12-01T00:00:00Z